Proof-of-concept research seeks to reduce glioblastoma drug toxicity through improved BBB delivery.
Researchers have identified a biomarker that appears to be elevated in the blood of those with aggressive neuroblastoma – findings that could potentially result in a prognostic test.
Researchers from the KTH Royal Institute of Technology (Stockholm, Sweden) have developed a cheap method of examining individual leukemia cells, which could be utilized to improve treatment.
This editorial discusses, summarizes and synthesizes the existing literature on posthumous reproduction in cancer patients according to the four principals of medical ethics: autonomy, justice, beneficence and nonmaleficence.
In this study, the researchers analyzed potential epigenetic mechanisms of combinatorial treatment with GTP/EGCG and BSp/SFN and their chemopreventive effects in a novel breast cancer cellular model, which resembles the processes of pathological progression and molecular events during earlier breast tumorigenesis.
This case study aims to describe the HTA processes and methods used in the adoption of an essential cancer drug such as trastuzumab in a selection of emerging countries in the use of HTA from the central, eastern and south eastern Europe (CESEE) and Latin America and the Caribbean (LAC) regions. The ultimate goal of this paper is to draw useful lessons for settings with evolving or newly-established HTA systems.